Algert Global LLC Invests $894,000 in Prestige Consumer Healthcare Inc (NYSE:PBH)

Algert Global LLC Invests $894,000 in Prestige Consumer Healthcare Inc (NYSE:PBH)

October 4, 2019 Off By administrator

Algert Global LLC purchased a new position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 28,212 shares of the company’s stock, valued at approximately $894,000. Algert Global LLC owned 0.06% of Prestige Consumer Healthcare at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of Prestige Consumer Healthcare by 0.7% during the 2nd quarter. Vanguard Group Inc. now owns 4,898,276 shares of the company’s stock worth $155,177,000 after acquiring an additional 32,075 shares during the period. Sterling Capital Management LLC lifted its stake in Prestige Consumer Healthcare by 110.5% in the 2nd quarter. Sterling Capital Management LLC now owns 1,115,214 shares of the company’s stock valued at $35,330,000 after purchasing an additional 585,326 shares during the last quarter. Ellington Management Group LLC bought a new position in shares of Prestige Consumer Healthcare during the second quarter valued at $580,000. Coatue Management LLC bought a new position in shares of Prestige Consumer Healthcare during the second quarter valued at $714,000. Finally, BlackRock Inc. raised its stake in shares of Prestige Consumer Healthcare by 3.4% during the second quarter. BlackRock Inc. now owns 6,455,495 shares of the company’s stock valued at $204,510,000 after acquiring an additional 214,690 shares during the last quarter.

PBH has been the subject of several recent analyst reports. TheStreet upgraded shares of Prestige Consumer Healthcare from a “d+” rating to a “c-” rating in a research report on Tuesday, July 23rd. ValuEngine upgraded shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research report on Friday, July 26th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $61.07.

PBH opened at $34.38 on Friday. The company has a debt-to-equity ratio of 1.63, a current ratio of 2.16 and a quick ratio of 1.26. The company’s 50-day moving average is $33.31 and its 200 day moving average is $31.18. Prestige Consumer Healthcare Inc has a fifty-two week low of $26.25 and a fifty-two week high of $41.76. The firm has a market capitalization of $1.78 billion, a P/E ratio of 12.37, a PEG ratio of 1.89 and a beta of 0.89.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 1st. The company reported $0.65 earnings per share for the quarter, beating analysts’ consensus estimates of $0.64 by $0.01. The company had revenue of $232.15…

(Excerpt) To read the full article , click here
Image credit: source